These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10705520)

  • 1. Effect of polymer excipients on the enzyme activity of lyophilized bilirubin oxidase and beta-galactosidase formulations.
    Yoshioka S; Aso Y; Kojima S; Tanimoto T
    Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):283-5. PubMed ID: 10705520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of excipients on the molecular mobility of lyophilized formulations, as measured by glass transition temperature and NMR relaxation-based critical mobility temperature.
    Yoshioka S; Aso Y; Kojima S
    Pharm Res; 1999 Jan; 16(1):135-40. PubMed ID: 9950292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation and aggregation of beta-galactosidase in lyophilized formulation described by Kohlrausch-Williams-Watts stretched exponential function.
    Yoshioka S; Tajima S; Aso Y; Kojima S
    Pharm Res; 2003 Oct; 20(10):1655-60. PubMed ID: 14620522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high molecular mobility of poly(vinyl alcohol) on protein stability of lyophilized gamma-globulin formulations.
    Yoshioka S; Aso Y; Nakai Y; Kojima S
    J Pharm Sci; 1998 Feb; 87(2):147-51. PubMed ID: 9519145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of local mobility in aggregation of beta-galactosidase lyophilized with trehalose, sucrose or stachyose.
    Yoshioka S; Miyazaki T; Aso Y; Kawanishi T
    Pharm Res; 2007 Sep; 24(9):1660-7. PubMed ID: 17404806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-relaxation of insulin molecule in lyophilized formulations containing trehalose or dextran as a determinant of chemical reactivity.
    Yoshioka S; Miyazaki T; Aso Y
    Pharm Res; 2006 May; 23(5):961-6. PubMed ID: 16715386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of storage stability of lyophilized actin using combinations of disaccharides and dextran.
    Allison SD; Manning MC; Randolph TW; Middleton K; Davis A; Carpenter JF
    J Pharm Sci; 2000 Feb; 89(2):199-214. PubMed ID: 10688749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence of the molecular mobility and protein stability of freeze-dried gamma-globulin formulations on the molecular weight of dextran.
    Yoshioka S; Aso Y; Kojima S
    Pharm Res; 1997 Jun; 14(6):736-41. PubMed ID: 9210190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of melibiose and trehalose as stabilising excipients for spray-dried β-galactosidase formulations.
    Lipiäinen T; Räikkönen H; Kolu AM; Peltoniemi M; Juppo A
    Int J Pharm; 2018 May; 543(1-2):21-28. PubMed ID: 29567196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage.
    Lueckel B; Helk B; Bodmer D; Leuenberger H
    Pharm Dev Technol; 1998 Aug; 3(3):337-46. PubMed ID: 9742554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using dextran of different molecular weights to achieve faster freeze-drying and improved storage stability of lactate dehydrogenase.
    Larsen BS; Skytte J; Svagan AJ; Meng-Lund H; Grohganz H; Löbmann K
    Pharm Dev Technol; 2019 Mar; 24(3):323-328. PubMed ID: 29781745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature- and glass transition temperature-dependence of bimolecular reaction rates in lyophilized formulations described by the Adam-Gibbs-Vogel equation.
    Yoshioka S; Aso Y; Kojima S
    J Pharm Sci; 2004 Apr; 93(4):1062-9. PubMed ID: 14999742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mobility of protein in lyophilized formulations linked to the molecular mobility of polymer excipients, as determined by high resolution 13C solid-state NMR.
    Yoshioka S; Aso Y; Kojima S; Sakurai S; Fujiwara T; Akutsu H
    Pharm Res; 1999 Oct; 16(10):1621-5. PubMed ID: 10554107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excipients for the lyoprotection of MAPKAP kinase 2 inhibitory peptide nano-polyplexes.
    Mukalel AJ; Evans BC; Kilchrist KV; Dailing EA; Burdette B; Cheung-Flynn J; Brophy CM; Duvall CL
    J Control Release; 2018 Jul; 282():110-119. PubMed ID: 29709529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development of lyophilized, long-term stable siRNA/oligoaminoamide polyplexes.
    Kasper JC; Troiber C; Küchler S; Wagner E; Friess W
    Eur J Pharm Biopharm; 2013 Oct; 85(2):294-305. PubMed ID: 23747745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of humidity on the phase behavior of API/polymer formulations.
    Prudic A; Ji Y; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2015 Aug; 94():352-62. PubMed ID: 26117187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilizing effect of four types of disaccharide on the enzymatic activity of freeze-dried lactate dehydrogenase: step by step evaluation from freezing to storage.
    Kawai K; Suzuki T
    Pharm Res; 2007 Oct; 24(10):1883-90. PubMed ID: 17486434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of glass transition temperature of freeze-dried formulations by molecular dynamics simulation.
    Yoshioka S; Aso Y; Kojima S
    Pharm Res; 2003 Jun; 20(6):873-8. PubMed ID: 12817890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of polymeric excipient properties on crystal hydrate formation kinetics of caffeine in aqueous slurries.
    Gift AD; Southard LA; Riesberg AL
    J Pharm Sci; 2012 May; 101(5):1755-62. PubMed ID: 22271407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyophilized formulations of recombinant tumor necrosis factor.
    Hora MS; Rana RK; Smith FW
    Pharm Res; 1992 Jan; 9(1):33-6. PubMed ID: 1589406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.